Status Approved
First Submitted Date
2021/03/29
Registered Date
2021/04/07
Last Updated Date
2022/12/16
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0006063 |
---|---|
Unique Protocol ID | CNUH-2021-100 |
Public/Brief Title | Financial InceNtives for cArdiac rehabilitioN ComplEtion (FINANCE) (Single blind Pragmatic RCT) |
Scientific Title | Financial InceNtives for cArdiac rehabilitioN ComplEtion (FINANCE) (Single blind Pragmatic RCT) |
Acronym | FINANCE |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | CNUH-2021-100 |
Approval Date | 2021-03-29 |
Institutional Review Board Name | Chonnam national university hospital institutional review board |
Institutional Review Board Address | 3dong 5 floor IRB administration office, Chonnam national university hospital, 42, Jebong-ro, Dong-gu, Gwangju |
Institutional Review Board Telephone | 062-220-5257 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Jae -Young Han |
Title | M.D.,Ph.D |
Telephone | +82-62-220-5198 |
Affiliation | Chonnam National University Hospital |
Address | Department of Physical medicine and Rehabilitation, 42, Jebong-ro, Dong-gu, Gwangju |
Contact Person for Public Queries | |
Name | Hae Young Yu |
Title | B.S |
Telephone | +82-62-1566-5186 |
Affiliation | Chonnam National University Hospital |
Address | Department of Physical medicine and Rehabilitation, 42, Jebong-ro, Dong-gu, Gwangju |
Contact Person for Updating Information | |
Name | Min A Jeong |
Title | B.S |
Telephone | +82-62-220-5198 |
Affiliation | Chungnam National University Hospital |
Address | Department of Physical medicine and Rehabilitation, 282 Munhwa-ro, Jung-gu Daejeon |
4. Status
Study Site | Multi-center Number of center : 2 | |
---|---|---|
Overall Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-04-27 Actual | |
Target Number of Participant | 48 | |
Primary Completion Date | 2023-06-30 , Anticipated | |
Study Completion Date | 2023-06-30 , Anticipated | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Chungnam National University Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-04-27 , | |
Recruitment Status by Participating Study Site 2 | ||
Name of Study | Chonnam National University Hospital | |
Recruitment Status | Recruiting | |
Date of First Enrollment | 2021-07-01 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | National Institute of Health |
Organization Type | Government |
Project ID | 2020ER630500 |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Chonnam National University Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | (1) Research purpose This study intends to confirm the effect of enhancing the participation and completion rates in patients who are referred for cardiac rehabilitation by comparing those in the group that receives incentives and those in the group that does not receive incentives for cardiac rehabilitation. (2) Clinical research plan A total of 48 participants are required for this clinical research. Participants who voluntarily sign the participation consent form will be reviewed by the inclusion and exclusion criteria according to the clinical research plan. Once the participants are reviewed as suitable for this trial, they will be randomly assigned to the 'incentive group' or the 'control group' with 24 participants in each group. Exercise rehabilitation program will be conducted on both the groups three times a week for three months, for a total of 36 sessions. Evaluation will be conducted through baseline and chart review, after the end of the exercise rehabilitation program (3 months) and at 6 months and 12 months respectively. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Health Services Research |
Phase | Not applicable |
Intervention Model | Parallel |
Blinding/Masking | Single |
Blinded Subject | Investigator, Outcome Accessor |
Allocation | RCT |
Intervention Type | Behavioral |
Intervention Description | The same 36 sessions of exercise rehabilitation program will be provided to both groups. Incentive provided to the group: - Incentives: 5,000 won each for the first 12 visits (1-12th session) (total 60,000 won), 10,000 won each for the next 12 visits (13th-24th session) (total 120,000 won), 15,000 won each for the last 12 visits (25th-36th session) (total 180,000 won), and transportation expenses of 360,000 won will be paid if the participant attends all 36 sessions. The control group will not receive any payment. |
Number of Arms | 2 |
Arm 1 |
Arm Label Incentive group |
Target Number of Participant 24 |
|
Arm Type Experimental |
|
Arm Description : Incentive will be provided for participation in all 36 outpatient exercise programs. - Incentives: 5,000 won each for the first 12 visits (1-12th session) (total 60,000 won), 10,000 won each for the next 12 visits (13th-24th session) (total 120,000 won), 15,000 won each for the last 12 visits (25th-36th session) (total 180,000 won), and transportation expenses of 360,000 won will be paid if the participant attends all 36 sessions. |
|
Arm 2 |
Arm Label control group |
Target Number of Participant 24 |
|
Arm Type No intervention |
|
Arm Description Control and incentive groups both will participate in the same 36 outpatient exercise programs. |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (I00-I99)Diseases of the circulatory system (I25.9)Chronic ischaemic heart disease, unspecified Cardiovascular disease |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 19Year~84Year |
|
Description : Male and female patients aged ≥19 years or above and <85 years : Patients who have been hospitalized for cardiovascular disease and are referred for multidisciplinary cardiac rehabilitation consultation after acute treatment : Patients who consent to participate in cardiac rehabilitation and as participants of the research |
|
Exclusion Criteria |
: Patients who are contraindicated for cardiopulmonary test and exercise training or patients who have difficulties in participating in this study due to other medical reasons or are excluded as per the researcher’s discretion (Contraindications: unstable angina symptoms, acute myocardial infarction (within 2 days), uncontrolled ventricular arrhythmia, third-degree atrioventricular block without artificial pacemaker, acute congestive heart failure, severe aortic stenosis, acute systemic disease, thrombophlebitis, thrombosis, active or suspected myocarditis, pericarditis) : Patients who are judged to be at risk of developing serious health problems from the exercise training |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Cardiac rehabilitation participation rate (number of participations out of the 36 exercise programs) |
|
Timepoint | 3 months, at the end of the exercise program |
|
Primary Outcome(s) 2 | ||
Outcome | Cardiac rehabilitation completion rate (participation of patients in 18 or more out of 36 exercise programs) |
|
Timepoint | 3 months, at the end of the exercise program |
|
Primary Outcome(s) 3 | ||
Outcome | PROM (Patient-Reported Outcome Measures) (KASI, EQ-5D, PHQ-9, CCI, physical activity) |
|
Timepoint | - Baseline, 3 months, 6 months, 12 months |
|
Secondary Outcome(s) 1 | ||
Outcome | Cardiopulmonary function index (VO2 max, VO2 at AT, MET, etc.) |
|
Timepoint | - Baseline, 3 months, 6 months, 12 months |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동